Form 8-K · Current report
American Express 8-K, filed Oct 30, 2026
- Filed
- CIK
- 0000004962
- Accession no.
- 0000004962-26-000411
Summary
American Express Company issued $3 billion in senior notes on October 30, 2026: $1.5 billion of 5.447% fixed-to-floating rate notes due 2030, $1.15 billion of 5.817% fixed-to-floating rate notes due 2034, and $350 million of floating rate notes due 2030, issued under its existing senior indenture with The Bank of New York Mellon as trustee.
Key points
- The notes were issued under a senior indenture dated August 1, 2007 with The Bank of New York Mellon as trustee, as amended by supplemental indentures dated February 12, 2021 and May 1, 2023.
- The offering was made under a prospectus supplement dated October 26, 2026 to a prospectus dated February 9, 2024, part of American Express's Form S-3 registration statement.
- The 5.447% fixed-to-floating notes and the floating rate notes both mature October 30, 2030; the 5.817% fixed-to-floating notes mature October 27, 2034.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
Items reported
- 8.01Other Events
- 9.01Financial Statements and Exhibits
From the filing
Item 8.01 Other Events. Exhibits are filed herewith in connection with the issuance by American Express Company (the “Company”), on October 30, 2026, of $1,500,000,000 aggregate principal amount of 5.447% Fixed-to-Floating Rate Notes due October 30, 2030, $1,150,000,000 aggregate principal amount of 5.817% Fixed-to-Floating Rate Notes due October 27, 2034 and $350,000,000 aggregate principal amount of Floating Rate Notes due October 30, 2030 (collectively, the “Notes”) pursuant to a Prospectus Supplement dated October 26, 2026 to the Prospectus dated February 9, 2024, filed as part of the Company’s Registration Statement on Form S-3 (No. 333-276975). …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.